Easywell Biomedicals, Inc.

TPEX:1799 Rapporto sulle azioni

Cap. di mercato: NT$11.2b

Easywell Biomedicals Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Easywell Biomedicals has a total shareholder equity of NT$745.2M and total debt of NT$44.5M, which brings its debt-to-equity ratio to 6%. Its total assets and total liabilities are NT$1.4B and NT$653.8M respectively.

Informazioni chiave

6.0%

Rapporto debito/patrimonio netto

NT$44.45m

Debito

Indice di copertura degli interessin/a
ContantiNT$433.19m
Patrimonio nettoNT$745.19m
Totale passivitàNT$653.80m
Totale attivitàNT$1.40b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Feb 12
What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Analisi della posizione finanziaria

Passività a breve termine: 1799's short term assets (NT$676.7M) exceed its short term liabilities (NT$168.3M).

Passività a lungo termine: 1799's short term assets (NT$676.7M) exceed its long term liabilities (NT$485.5M).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 1799 has more cash than its total debt.

Riduzione del debito: 1799's debt to equity ratio has reduced from 13.5% to 6% over the past 5 years.


Bilancio


Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: 1799 has sufficient cash runway for more than a year based on its current free cash flow.

Previsione Cash Runway: 1799 has sufficient cash runway for 1.4 years if free cash flow continues to grow at historical rates of 15.1% each year.


Scoprire le aziende sane